Supplementary Table 1 from First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors

Autor:	Jean-Charles Soria, Valerie Meresse Naegelen, Steve Blotner, Eliezer Shochat, Jean J. L. Tessier, Ruediger Rueger, Zhi-Xin Xu, Ernesto Guarin, Emilie Routier, Federico Rojo, Françoise Kraeber-Bodéré, Saoirse Dolly, Rastilav Bahleda, Joan Albanell, Udai Banerji, Maria Martinez-Garcia
Rok vydání:	2023
DOI:	10.1158/1078-0432.22451102.v1
Popis:	PDF file, 9K, Summary of pharmacokinetics of RO4987655 in patients following oral administration.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088e1989b219d8b25cb6ff3d615e9d0d https://doi.org/10.1158/1078-0432.22451102.v1 Zobrazit plný text záznamu